《业绩》晶泰控股(02228.HK)上半年经调整利润近1.42亿人币 首次实现半年盈利

阿斯达克财经
Yesterday

本港首只上市特专科技股、主打智能机器人解决方案及AI药物发现的晶泰控股(02228.HK) 公布6月底止中期业绩,实现营业收入5.17亿元人民币(下同),按年增长403.8%。按年扭亏为盈,录纯利8,279.5万元,对上财年同期蚀12.37亿元;每股盈利1.51分。不派息。

过往派息
公布日期派息事项派息内容
2025/03/28末期业绩无派息
2024/08/28中期业绩无派息

非国际财务报告准则(non-IFRS)计,上半年转录经调整利润近1.42亿元,首次实现半年盈利,对上财年同期录经调整亏损2.51亿元。集团财务状况良好,公司上半年月均现金消耗降低20%至4,970万元。

期内药物发现解决方案业务收入按年增长615.2%至4.35亿元。这一增长主要得益于集团与DoveTree Medicines LLC及其联属公司开展重大合作。集团达成了该项合作的第一阶段里程碑,并收到首付款5,100万美元。此外,集团抗体业务产生的收入亦表现出强劲增长。
上半年集团智能机器人解决方案业务收入按年增长95.9%至约8,190万元。主要由自动化化学合成服务及XtaPi研发解决方案的高速增长驱动。(da/u)(港股报价延迟最少十五分钟。沽空资料截至 2025-08-27 16:25。)
AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10